Applications - Projects
Chimera Biotec is a service provider focused on innovative technologies to guarantee customer satisfaction. We combine interdisciplinary biologists and chemists to overcome current limitations in immunoassay technologies.
In addition to the continuous improvement of the ultrasensitive immunoPCR based Imperacer® method, we are working on a number of other forward-looking projects.
For more information on our funded projects click on the buttons at the left or below.
- Alzheimer’s disease by EU
The EDAR study establishes new biomarkers for Alzheimer’s disease. - Doping Test by WADA
An Immuno PCR fingerprint analysis is used for the high sensitive detection of manipulations in the myostatin signal transduction pathway. - Microfluidics by BMBF
Innovative biogenic magnetite nanoparticles are utilized for microarray and separation technology. - Lab-on-a-chip by ZWR
Trendsetting lab-on-a-chip applications are designed for fast handheld devices.
Chimera wants to thank the World Anti-Doping Agency, the European Union, the Zukunftswettbewerb Ruhrgebiet and the Bundesministerium für Bildung und Forschung for financial support and all collaborators for the productive teamwork.
